Related Experiment Video
Updated: Aug 18, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is
Shizhen Emily Wang1, Frederick Y Wu, Incheol Shin
1Division of Oncology, Department of Cancer Biology, Vanderbilt University School of Medicine, 2220 Pierce Ave., 777 PRB, Nashville, TN 37232-6307, USA.
Abstract:
Transforming growth factor beta (TGF-beta) inhibits proliferation and promotes cell migration. In TGF-beta-treated MCF10A mammary epithelial cells overexpressing HER2 and by chromatin immunoprecipitation, we identified novel Smad targets including protein tyrosine phosphatase receptor type kappa (PTPRK). TGF-beta up-regulated PTPRK mRNA and RPTPkappa (receptor type protein tyrosine phosphatase kappa, the protein product encoded by the PTPRK gene) protein in tumor and nontumor mammary cells; HER2 overexpression down-regulated its expression. RNA interference (RNAi) of PTPRK accelerated cell cycle progression, enhanced response to epidermal growth factor (EGF), and abrogated TGF-beta-mediated antimitogenesis. Endogenous RPTPkappa associated with EGF receptor and HER2, resulting in suppression of basal and ErbB ligand-induced proliferation and receptor phosphorylation. In MCF10A/HER2 cells, TGF-beta enhanced cell motility, FAK phosphorylation, F-actin assembly, and focal adhesion formation and inhibited RhoA activity. These responses were abolished when RPTPkappa was eliminated by RNA interference (RNAi). In cells expressing RPTPkappa RNAi, phosphorylation of Src at Tyr527 was increased and (activating) phosphorylation of Src at Tyr416 was reduced. These data suggest that (i) RPTPkappa positively regulates Src; (ii) HER2 signaling and TGF-beta-induced RPTPkappa converge at Src, providing an adequate input for activation of FAK and increased cell motility and adhesion; and (iii) RPTPkappa is required for both the antiproliferative and the promigratory effects of TGF-beta.
Insights
Transforming growth factor beta (TGF-beta) and HER2 signaling converge on protein tyrosine phosphatase receptor type kappa (PTPRK). PTPRK is essential for TGF-beta
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor beta (TGF-beta) is known to inhibit proliferation and promote cell migration.
- HER2 overexpression is implicated in various cellular processes, including mammary epithelial cell behavior.
Purpose of the Study:
- To identify novel Smad targets in TGF-beta-treated MCF10A mammary epithelial cells overexpressing HER2.
- To elucidate the role of protein tyrosine phosphatase receptor type kappa (PTPRK) in TGF-beta and HER2 signaling pathways.
Main Methods:
- Chromatin immunoprecipitation was used to identify Smad targets.
- RNA interference (RNAi) was employed to study the function of PTPRK.
- Western blotting and quantitative PCR were utilized to assess protein and mRNA expression levels.
- Cell proliferation, cell cycle progression, and cell motility assays were performed.
Main Results:
- PTPRK was identified as a novel Smad target, with TGF-beta up-regulating its expression and HER2 overexpression down-regulating it.
- RNAi of PTPRK accelerated cell cycle progression, enhanced EGF response, and abrogated TGF-beta-mediated antimitogenesis.
- RPTPkappa (the protein product of PTPRK) associated with EGFR and HER2, suppressing proliferation and receptor phosphorylation.
- TGF-beta-induced cell motility, FAK phosphorylation, and F-actin assembly were dependent on RPTPkappa.
- RPTPkappa positively regulates Src, with convergence of HER2 and TGF-beta signaling at Src.
Conclusions:
- RPTPkappa is a key mediator of both the antiproliferative and promigratory effects of TGF-beta.
- HER2 signaling and TGF-beta-induced RPTPkappa converge at Src, influencing cell motility and adhesion.
- PTPRK plays a critical role in regulating mammary epithelial cell behavior in response to TGF-beta and HER2 signaling.
Related Concept Videos
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

